Insulin-like growth factor in hemodialysis patients
- Conditions
- This project aims to investigate whether the anabolic potentials of insulin may be used to reverse the catabolic effects of hemodialysis in non-diabetic patients with end-stage renal failure. Thus, the project explores a potentially novel indication for insulin treatment of non-diabetic patients.MedDRA version: 12.1Level: LLTClassification code 10014647Term: End stage renal failure
- Registration Number
- EUCTR2010-020114-29-DK
- Lead Sponsor
- Department of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
age more than 18 years and stable, long-term maintenance hemodialysis.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
diabetes mellitus, pregnancy, body mass index < 18,5 kg/m2 or > 30 kg/m2, malignancy and the use of immunosuppressive drugs including glucocorticosteroids
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method